bone marrow transplantation, page-3

Unfortunately anything to do with Teva looks like its either been shelved or on hold. This product should have just about been at FDA approval stage but since the Teva takeover of cephalon looks to have been halted along with the heart trial.
The really frustrating thing is before Teva came into the picture we were full steam ahead and a share price nearly double where we are at now.
I believe in the science and the efficacy of our MPCs but unfortunately our partnership with TEVA has set us a couple of years back in progress and whether its the professor not willing to budge a little on the outstanding deal he did with cephalon or Teva playing the our way or the highway card who knows but in the end it's us the sharehders left in the dark .
I really hope they can come to an agreement soon because it will tarnish any other good news that should be forthcoming ie diabetes and disc.